Abstract
Enhanced fetal γ-globin synthesis alleviates symptoms of β-globinopathies such as sickle cell disease and β-thalassemia, but current γ-globin–inducing drugs offer limited beneficial effects. We show here that lysine-specific demethylase 1 (LSD1) inhibition by RNAi in human erythroid cells or by the monoamine oxidase inhibitor tranylcypromine in human erythroid cells or β-type globin–transgenic mice enhances γ-globin expression. LSD1 is thus a promising therapeutic target for γ-globin induction, and tranylcypromine may serve as a lead compound for the development of a new γ-globin inducer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Testa, U. Ann. Hematol. 88, 505–528 (2009).
Tanabe, O. et al. EMBO J. 21, 3434–3442 (2002).
Tanabe, O. et al. EMBO J. 26, 2295–2306 (2007).
Cui, S. et al. Mol. Cell Biol. 31, 3298–3311 (2011).
Shi, Y. et al. Cell 119, 941–953 (2004).
Hu, X. et al. Proc. Natl. Acad. Sci. USA 106, 10141–10146 (2009).
Saleque, S., Kim, J., Rooke, H.M. & Orkin, S.H. Mol. Cell 27, 562–572 (2007).
Lee, M.G., Wynder, C., Schmidt, D.M., McCafferty, D.G. & Shiekhattar, R. Chem. Biol. 13, 563–567 (2006).
Mallinger, A.G. & Smith, E. Psychopharmacol. Bull. 27, 493–502 (1991).
Wang, J. et al. Nat. Genet. 41, 125–129 (2009).
Moutouh-de Parseval, L.A. et al. J. Clin. Invest. 118, 248–258 (2008).
Banzon, V. et al. Exp. Hematol. 39, 26–36. e1 (2011).
Sankaran, V.G. et al. Nature 460, 1093–1097 (2009).
Buller, A.M., Elford, H.L., DuBois, C.C., Meyer, J. & Lloyd, J.A. Blood Cells Mol. Dis. 25, 255–269 (1999).
Xu, J. et al. Science 334, 993–996 (2011).
Menzel, S. et al. Nat. Genet. 39, 1197–1199 (2007).
Wilber, A., Nienhuis, A.W. & Persons, D.A. Blood 117, 3945–3953 (2011).
Frieling, H. & Bleich, S. Eur. Arch. Psychiatry Clin. Neurosci. 256, 268–273 (2006).
Sprüssel, A. et al. Leukemia 26, 2039–2051 (2012).
Eyer, F., Jetzinger, E., Pfab, R. & Zilker, T. Clin. Toxicol. (Phila.) 46, 261–263 (2008).
Giarratana, M.C. et al. Nat. Biotechnol. 23, 69–74 (2005).
Irizarry, R.A. et al. Biostatistics 4, 249–264 (2003).
Acknowledgements
This work was supported by US National Institutes of Health grants DK086956 (to O.T. and J.D.E.) and HL24415 (to J.D.E.) and an American Heart Association postdoctoral fellowship to L.S. We thank D. Giacherio and D. Harro for hemoglobin HPLC analysis; C. Yu, A.D. Campbell, K.C. Lim, T. Hosoya, B. Godfrey and M. Sierant for discussions, comments and technical assistance; and D. Lavelle and J. DeSimone for discussions regarding the inductive properties of decitabine. Lentiviruses were produced by the University of Michigan Vector Core. Microarray analysis was performed at the University of Michigan Microarray Core.
Author information
Authors and Affiliations
Contributions
O.T. and J.D.E. conceived of the study; L.S., S.C., J.D.E. and O.T. designed experiments. L.S. and S.C. performed experiments. L.S., S.C., J.D.E. and O.T. analyzed data and wrote the paper.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–9 and Supplementary Tables 1–4 (PDF 2950 kb)
Rights and permissions
About this article
Cite this article
Shi, L., Cui, S., Engel, J. et al. Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction. Nat Med 19, 291–294 (2013). https://doi.org/10.1038/nm.3101
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3101
This article is cited by
-
CRISPR-Cas9 mediated genome editing of Huntington’s disease neurospheres
Molecular Biology Reports (2023)
-
Down-regulation of the transcriptional repressor ZNF802 (JAZF1) reactivates fetal hemoglobin in β0-thalassemia/HbE
Scientific Reports (2022)
-
Revisiting fetal hemoglobin inducers in beta-hemoglobinopathies: a review of natural products, conventional and combinatorial therapies
Molecular Biology Reports (2022)
-
Genome-based therapeutic interventions for β-type hemoglobinopathies
Human Genomics (2021)
-
Predictive biomarkers and potential drug combinations of epi-drugs in cancer therapy
Clinical Epigenetics (2021)